Coronavirus COVID-19 Daily Update 12th April 2020

Coronavirus COVID-19 Daily Update 12th April 2020

This update will be published daily at 12pm GMT and aims to provide clinicians and the public with an overview of the latest data, guidelines, key publications and policy around COVID-19, with links to essential resources and information.


If you are a healthcare professional, please join the discussion on these latest COVID-19 cases on MedShr:

Please post any COVID-19 cases, images or learning points from your clinical practice on MedShr - share key knowledge and experience with a global network of doctors to help improve patient care. Include #COVID19 in your case title.


Please email COVID@medshr.net if you have any data, publications or information you would like to share.

Global Impact of COVID-19 to Date

As of 12th April 09:00 (GMT)

COVID-19 Cumulative Global Cases

As of 12th April 09:00 (GMT)

COVID-19 Global Active Cases Map

As of 12th April 09:00 GMT

Total UK COVID-19 Cases

As of 11th April

NB: Public Health England has now moved to a different reporting time for UK COVID-19 fatalities, as family consent is now needed to release mortality statistics. Hence the reported figures may not actually be the deaths that have taken place over the past 24 hours, meaning caution needs to be exercised when comparing figures from one day to the next.

COVID-19 Cumulative UK Cases

As of 11th April

COVID-19 Daily UK Cases

As of 11th April

Source: Nature Middle East (last updated 2nd April 2020)


COVID-19 Key Data

Latest Developments


Africa

Asia

Middle East

Europe

United Kingdom

USA

Latest COVID-19 Publications

Some key recent publications to be aware of:

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Published online ahead of print
Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Considering minimal risk upon use, a long experience of use in other diseases, cost-effectiveness and easy availability across India, we propose that both these drugs are worthy of fast track clinical trial for treatment, and may be carefully considered for clinical use as experimental drugs.

A role for CT in COVID-19? What data really tell us so far

Michael D Hope, Constantine A Raptis, Amar Shah, Mark M Hammer, Travis S Henry on behalf of six signatories

Published: March 27, 2020

The authors of this correspondence appraise the evidence which suggested CT could have a pivotal role in COVID-19 diagnosis and highlight some of the pitfalls.  Centrally, CT findings identified in COVID-19 are not specific to this pathogen, and are found in many other disease processes (infective and non-infective). Additionally, when groups of COVID-19 patients who had not been admitted to hospital were studied, most did not have CT changes.   They caution that CT scanners could become vectors of transmission if used inappropriately.



Comments

Sign in or Register to comment


Matching media queries: